home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  


  June, 22 2000 5:47
your information resource in human molecular genetics

The first evidence emerges this week that it may one day be possible to treat neurodegenerative disease and central nervous system (CNS) injury by stimulating the growth and development of neural precursor cells.

In tissues that can repair themselves, such as skin and liver, dead cells may be replaced by the proliferation of nearby cells or by the activation of resident stem cells - undifferentiated cells with the potential to generate many different cell types. The brain apparently lacks this regenerative capacity, making it particularly vulnerable to injury or disease.

Cells with stem-cell-like properties are thought to occur throughout the adult CNS, but normally they give rise to neurons in only a few, restricted areas. Now Jeffrey D. Macklis, and colleagues of Harvard Medical School, Boston, Massachusetts, present work (Nature, Vol. 405, Issue 6789, June 22, 2000) suggesting that these cells can be mobilized to generate new functional neurons to repair injury.

Anders Björklund and Olle Lindvall, at Lund University, Sweden, discuss this exciting work in an accompanying News and Views article.


  • Jeffrey D. Macklis tel +1 617 355 7185/7219, fax +1 617 355 3636,
    e-mail macklis@a1.tch.harvard.edu
  • Anders Björklund tel +46 46 222 0540/1, fax +46 46 222 0559,
    e-mail anders.bjorklund@mphy.lu.se
  • (C) Nature press release.

    Message posted by: Trevor M. D'Souza

    print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.